BioBots, a Weiss Tech House Innovation Fund start-up producing 3-D bioprinters that have revolutionized labs across the U.S., has recently changed its name to Allevi.
Ricky Solorzano, CEO of BioBots, says Allevi was “inspired by our community of users who work every day to make living solutions for humanity’s most important problems- to cure disease, to alleviate suffering, to build with life.” Allevi’s mission is to change the course of medicine for generations to come, and to influence the world with their ingenious product.
Allevi also recently launched a new software that aims to standardize experimental methodology and workflow in the field biofabrication. This new software aims to make bioprinting easier and more accessible. The new software can be found here.